These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 5535050)

  • 21. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
    Jenkins AC; Schwieger AC
    Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186
    [No Abstract]   [Full Text] [Related]  

  • 22. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R; de Ajuriaguerra J
    Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
    [No Abstract]   [Full Text] [Related]  

  • 23. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 24. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL; Weiner WJ
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):427-30. PubMed ID: 4838914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [L-dopa induced psychosis-dyskinesia complex].
    Ikeda H; Baba O; Ishino H
    No To Shinkei; 1972 Mar; 14(3):275-80. PubMed ID: 5067044
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract]   [Full Text] [Related]  

  • 27. L-dopa. II.
    Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003
    [No Abstract]   [Full Text] [Related]  

  • 28. [L-Dopa in the treatment of Parkinson's disease].
    Warot P
    Lille Med; 1971; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract]   [Full Text] [Related]  

  • 29. L-dopa--long-term effects.
    Del Med J; 1971 Aug; 43(8):236. PubMed ID: 5094610
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
    Kaufmann W; Butz P; Wiesendanger M
    Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658
    [No Abstract]   [Full Text] [Related]  

  • 31. [One year of experience with L-Dopa in Parkinson's disease].
    Henry P; Lacut JY; Pouget-Abadie J; Bergouignan M; Leng-Lĕvy J
    Bord Med; 1971 May; 4(5):1581-91. PubMed ID: 5569952
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease].
    Paciaroni E; Raspa EG
    Sist Nerv; 1970; 22(2):153-61. PubMed ID: 5504554
    [No Abstract]   [Full Text] [Related]  

  • 33. L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients).
    Fincham RW; Decker DA
    J Iowa Med Soc; 1970 Nov; 60(11):755-9. PubMed ID: 5482403
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA; Campanella G
    Acta Neurol (Napoli); 1971; 26(1):46-60. PubMed ID: 5553941
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases].
    Pimenta Ada M; Friguglietti DJ
    Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650
    [No Abstract]   [Full Text] [Related]  

  • 37. An evaluation of L-dopa in Parkinson patients.
    Mones RJ
    Trans Am Neurol Assoc; 1969; 94():307-9. PubMed ID: 5374472
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical remarks on the action of intravenous and oral levo-dopa in the treatment of Parkinson's disease (135 cases)].
    Fasano VA; Urciuoli R; Broggi G; Cannella M; Lombard GF
    Neurochirurgie; 1970; 16(2):171-8. PubMed ID: 5451127
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 40. [Two years experience with L-DOPA in association with a decarboxylase inhibitor].
    Siegfried J
    Rev Neurol (Paris); 1970 Apr; 122(4):243-8. PubMed ID: 5472041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.